Anti-Lymphocyte Activation Gene 3 antibody [11E3] (ab40465)

Publishing research using ab40465? Please let us know so that we can cite the reference in this datasheet.

ab40465 has been referenced in 2 publications.

  • Takada K  et al. Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer. J Transl Med 16:86 (2018). IHC-P ; Human . PubMed: 29615076
  • Huard B  et al. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc Natl Acad Sci U S A 94:5744-9 (1997). PubMed: 9159144

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up